Devyser Diagnostics Logo

Devyser Diagnostics

Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.

DVYSR | ST

Overview

Corporate Details

ISIN(s):
SE0016588867 (+1 more)
LEI:
549300RV4Z2K3360CK30
Country:
Sweden
Address:
Instrumentvägen 19, 126 53 Hägersten
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Devyser Diagnostics is a company specializing in the development, manufacture, and sale of advanced diagnostic kits for genetic DNA testing. Serving clinical laboratories, its product portfolio addresses critical areas such as reproductive health, oncology for guiding targeted cancer therapies, and post-transplant monitoring. Devyser's core mission is to simplify and streamline complex laboratory workflows by providing fast, accurate, and user-friendly solutions. The company's end-to-end tests are designed to significantly reduce sample-to-result times and manual handling, aiming to enhance laboratory efficiency, enable quicker patient diagnoses, and advance the accessibility of personalized medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Devyser Diagnostics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Devyser Diagnostics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Mia Arnhult Other Buy 7,000 745,290.00 SEK

Peer Companies

Company Country Ticker View
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany N/A
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875
Medicon Hellas S.A. Logo
Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.
Greece MEDIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.